Skip to main content

Table 2 (abstract P40). Remission rates in respect to different treatment modalities.

From: 9th European Conference on Rare Diseases & Orphan Products (ECRD Vienna 2018)

Mode of treatment

Remission rates (% of patients)

Total number of patients

Overall

51.4

534

Overall after introduction of SSA

70.3

219

Surgery

28.8

486

Adjuvant CAB without prior Ro

18.2

70

Adjuvant SSA

38.6

70

Conventional radiotherapy

34.6

159

  1. CAB Cabergoline, Ro radiotherapy, SSA somatostatin analogs